Activities of Moxifloxacin Alone and in Combination with Other Antimicrobial Agents against Multidrug-Resistant Mycobacterium tuberculosis Infection in BALB/c Mice
Open Access
- 1 January 2003
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (1) , 360-362
- https://doi.org/10.1128/aac.47.1.360-362.2003
Abstract
The activity of moxifloxacin was enhanced by the addition of ethionamide but not by that of cycloserine, thiacetazone, capreomycin, para -aminosalicylic acid, or linezolid in BALB/c mice infected with a strain of Mycobacterium tuberculosis resistant to isoniazid, rifampin, and six other drugs. These observations are important for the therapy of multidrug-resistant tuberculosis.Keywords
This publication has 14 references indexed in Scilit:
- Bactericidal Activity of Increasing Daily and Weekly Doses of Moxifloxacin in Murine TuberculosisAntimicrobial Agents and Chemotherapy, 2002
- In Vitro and In Vivo Activities of Gatifloxacin against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2002
- Effectiveness of Once-Weekly Rifapentine and Moxifloxacin Regimens against Mycobacterium tuberculosis in MiceAntimicrobial Agents and Chemotherapy, 2001
- The Treatment of Multidrug-Resistant Tuberculosis in TurkeyNew England Journal of Medicine, 2001
- Treatment of multidrug-resistant tuberculosisPublished by Springer Nature ,2000
- Activity of 16 Antimicrobial Agents Against Drug-Resistant Strains ofMycobacterium tuberculosisMicrobial Drug Resistance, 1999
- Activities of poloxamer CRL8131 against Mycobacterium tuberculosis in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1995
- Therapy of multidrug-resistant tuberculosis: lessons from studies with miceAntimicrobial Agents and Chemotherapy, 1993
- Killing of intracellular Mycobacterium tuberculosis by receptor-mediated drug deliveryAntimicrobial Agents and Chemotherapy, 1991
- Experimental Evaluation of EfficacyPublished by Springer Nature ,1988